Last updated on February 2018

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma


Brief description of study

The aim of the study is to see if there any changes in the quality of life for patients that are undergoing radical prostatectomy.

Detailed Study Description

Liver cancer is a deadly cancer that is typically hard to diagnose and treat. The currently used blood marker for the clinical diagnosis of liver cancer is alpha-feto protein (AFP), which misses 40-60% of patients with liver cancer because it lacks sufficient specificity and sensitivity. The purpose of this study is to identify blood markers that have the ability to diagnose liver cancer with improved accuracy, so that it can be used alone or in conjunction with AFP. The aim of this study is to identify new blood markers of liver cancer that can be used to increase the rate of accurate diagnosis of this malignancy.

Clinical Study Identifier: NCT00373347

Contact Investigators or Research Sites near you

Start Over

Samuel So

Stanford University School of Medicine
Stanford, CA United States
  Connect »